POS-610 PREDICTORS OF ERYTHROPOIETIN HIPORESPONSIVENESS IN PREVALENT PATIENTS ON HEMODIALYSIS: A CROSS-SECTIONAL STUDY

POS-610 PREDICTORS OF ERYTHROPOIETIN HIPORESPONSIVENESS IN PREVALENT PATIENTS ON HEMODIALYSIS: A CROSS-SECTIONAL STUDY

Bibliographic Details
Main Authors:	M. ROLDÃO, E. Escoli, H. Gonçalves, F. Sofia, K. Lopes
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024921007853

Similar Items

Predictors of hyporesponsiveness to erythropoietin in prevalent hemodialysis patients and its association with mortality
by: Marisa Roldão, et al.
Published: (2022-03-01)

IL-6, malnutrition, and short-term mortality in prevalent hemodialysis patients
by: Marisa Roldão, et al.
Published: (2022-12-01)

POS-611 FERRITIN: ONE BIOMARKER, MULTIPLE INTERPRETATIONS
by: M. ROLDÃO, et al.
Published: (2021-04-01)

Vascular access type and mortality in elderly incident hemodialysis patients
by: Marisa Roldão, et al.
Published: (2023-07-01)

Vascular access type and mortality in elderly incident hemodialysis patients
by: Marisa Roldão, et al.
Published: (2023-07-01)

PTH Serum Levels and Mortality Risk among Incident Hemodialysis Patients
by: Marisa Roldão, et al.
Published: (2022-10-01)

Effectiveness of Erythropoietin in Hypertensive Hemodialysis Patients
by: Susannia Ibrahim, et al.
Published: (2017-08-01)

Erythropoietin hyporesponsiveness among egyptian hemodialysis patients
by: Salah Eldin Khedr PhD, et al.
Published: (2017-06-01)

Association between Anti-Erythropoietin Receptor Antibodies and Cardiac Function in Patients on Hemodialysis: A Multicenter Cross-Sectional Study
by: Yasuhiro Mochida, et al.
Published: (2022-08-01)

Prevalence, clinical characteristics, and predictors of peripheral arterial disease in hemodialysis patients: a cross-sectional study
by: Radislav R. Ašćerić, et al.
Published: (2019-07-01)

POS-594 INCIDENT VERSUS PREVALENT EGYPTIAN HEMODIALYSIS PATIENTS AND THEIR MORTALITY PREDICTORS: A MULTICENTER PROSPECTIVE STUDY
by: A.F. MEGAHED, et al.
Published: (2021-04-01)

Obesity may be erythropoietin dose-saving in hemodialysis patients
by: Ghada M. El-Kannishy, et al.
Published: (2018-06-01)

Effectivity of Erythropoietin Alpha Compared to Erythropoietin Beta in Patients with Chronic Kidney Disease-Anemia on Hemodialysis
by: Anak Agung Ngurah Putra Riana Prasetya, et al.
Published: (2021-01-01)

Blood leptin levels and erythropoietin requirement in Iranian hemodialysis patients
by: Rahimi A, et al.
Published: (2008-12-01)

POS-617 GERIATIC HEMODIALYSIS PATIENTS: PREVALENCE AND RISK FACTORS
by: B.A. SHEDHA, et al.
Published: (2021-04-01)

Prevalence of depression and anxiety and their predictors among patients undergoing maintenance hemodialysis in Northern China: a cross-sectional study
by: Yan Meng, et al.
Published: (2022-12-01)

Skeletal muscle mass is associated with erythropoietin response in hemodialysis patients
by: Tomoaki Takata, et al.
Published: (2021-04-01)

Erythropoietin resistance in patients with regular hemodialysis in Sohag university hospital
by: Nagwa S. Ahmed, et al.
Published: (2023-06-01)

Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients
by: Amir-Hooshang Mohammadpour, et al.
Published: (2014-01-01)

POS-091 PREVALENCE AND DETERMINANTS OF ERECTILE DYSFUNCTION IN HEMODIALYSIS PATIENTS
by: M. Ben Salem, et al.
Published: (2021-04-01)

Does erythropoietin therapy affect circulating endothelial cells in hemodialysis patients?
by: T. Bulduk, et al.
Published: (2020-10-01)

Impact of erythropoietin on anemia in end-stage renal disease patients on hemodialysis
by: Bashaer M Muhammad-Baqir, et al.
Published: (2023-01-01)

Gut Microbiota Correlates With Clinical Responsiveness to Erythropoietin in Hemodialysis Patients With Anemia
by: Yifan Zhu, et al.
Published: (2022-07-01)

The Effects of Erythropoietin in the Management of Anemia of Chronic Renal Failure in Patients on Hemodialysis
by: M Rahimian, et al.
Published: (2005-04-01)

Patient Activation Among Prevalent Hemodialysis Patients: An Observational Cross-Sectional Study
by: Wael F Hussein MRCPI, et al.
Published: (2022-07-01)

POS-563 PREVALENCE OF COVID 19 IN A HOSPITAL HEMODIALYSIS UNIT
by: N. Begoña Boldoba, et al.
Published: (2021-04-01)

Workshop manual for Datsun 510 and 610 series/
by: 245761 Newton, C. R.
Published: (1972)

Prevalence and predictors of heart failure among patients on maintenance hemodialysis therapy at Muhimbili National Hospital in Tanzania: a cross-sectional study
by: Puneet Kishore Bramania, et al.
Published: (2021-10-01)

Effects of L-Carnitine Added to Erythropoietin in Anemic Chronic Renal Failure Patients on Hemodialysis.
by: N Taheri, et al.
Published: (2006-10-01)

PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR:HEMODIALYSIS VSHEMODIAFILTRATION
by: V. Novakivskyy
Published: (2017-03-01)

Correlation between ultrafiltration rate and hemoglobin level and erythropoietin response in hemodialysis patients
by: Li Cui, et al.
Published: (2024-12-01)

Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients
by: Maryam Rahbar, et al.
Published: (2017-01-01)

Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients
by: Kristina Petrulienė, et al.
Published: (2017-01-01)

How the Duration Period of Erythropoietin Treatment Influences the Oxidative Status of Hemodialysis Patients
by: Zorica M. Dimitrijevic, Tatjana P. Cvetkovic, Vidojko M. Djordjevic, Dusica D. Pavlovic, Nikola Z. Stefanovic, Ivana R. Stojanovic, Goran J. Paunovic, Radmila M. Velickovic-Radovanovic
Published: (2012-01-01)

Interleukin-6 gene polymorphisms and serum erythropoietin and hemoglobin in hemodialysis Iraqi patients
by: Mohanad Yasir Al-Radeef, et al.
Published: (2018-01-01)

Effects of the route of erythropoietin administration on hemoglobin variability and cardiovascular events in hemodialysis patients
by: Do Hyoung Kim, et al.
Published: (2021-12-01)

Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients.
by: Myoung Nam Bae, et al.
Published: (2015-01-01)

Erythropoietin-Resistant Anemia Secondary to Zinc-Induced Hypocupremia in a Hemodialysis Patient
by: Stephanie Munie, et al.
Published: (2021-07-01)

AGW 610 - FINANCE ACCOUNTING FOR MANAGEMENT SEPT 99.
by: PPP, Pusat Pengajian Pengurusan
Published: (1999)

AGU 610 - INTERNATIONAL BUSINESS MANAGEMENT APRIL 08
by: PPP, Pusat Pengajian Pengurusan
Published: (2008)